Differential role of glucocorticoid receptor based on its cell type specific expression on tumor cells and infiltrating lymphocytes

preprint OA: closed
Full text JSON View at publisher
Full text 16,450 characters · extracted from preprint-html · click to expand
Differential role of glucocorticoid receptor based on its cell type specific expression on tumor cells and infiltrating lymphocytes | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Differential role of glucocorticoid receptor based on its cell type specific expression on tumor cells and infiltrating lymphocytes Snijesh V P, Vidya P. Nimbalkar, Sharada Patil, Savitha Rajarajan, and 8 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-3829052/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Background : The glucocorticoid receptor (GR) is frequently expressed in breast cancer (BC), and its prognostic implications are contingent on estrogen receptor (ER) status. To address conflicting reports and explore therapeutic potential, a GR signature (GRsig) independent of ER status was developed. We also investigated cell type-specific GR protein expression in BC tumor epithelial cells and infiltrating lymphocytes. Methods : GRsig was derived from Dexamethasone-treated cell lines through a bioinformatic pipeline. Immunohistochemistry assessed GR protein expression. Associations between GRsig and tumor phenotypes (proliferation, cytolytic activity (CYT), immune cell distribution, and epithelial-to-mesenchymal transition(EMT)) were explored in public datasets. Single-cell RNA sequencing data evaluated context-dependent GR roles, and a cell type-specific prognostic role was assessed in an independent BC cohort. Results : High GRsig levels were associated with a favorable prognosis across BC subtypes. Tumor-specific high GRsig correlated with lower proliferation, increased CYT, and anti-tumorigenic immune cells. Single-cell data analysis revealed higher GRsig expression in immune cells, negatively correlating with EMT while a positive correlation was observed with EMT primarily in tumor and stromal cells. Univariate and multivariate analyses demonstrated the robust and independent predictive capability of GRsig for favorable prognosis. GR protein expression on immune cells in triple-negative tumors indicated a favorable prognosis. Conclusion : This study underscores the cell type-specific role of GR, where its expression on tumor cells is associated with aggressive features like EMT, while in infiltrating lymphocytes, it predicts a better prognosis, particularly within TNBC tumors. The GRsig emerges as a promising independent prognostic indicator across diverse BC subtypes. Cancer Biology Bioinformatics Translational Medicine Oncology Glucocorticoid receptor Gene signature Proliferation Tumor microenvironment Epithelial to mesenchymal transition Prognosis Full Text Additional Declarations The authors declare no competing interests. Supplementary Figures and Tables are not available with this version. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-3829052","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":264719975,"identity":"2449e566-2511-4e01-8205-e4fd6f37150b","order_by":0,"name":"Snijesh V P","email":"","orcid":"https://orcid.org/0000-0002-2215-9042","institution":"Division of Molecular Medicine, St. John’s Medical College, St. John’s Research Institute, Bangalore, Karnataka, India","correspondingAuthor":false,"prefix":"","firstName":"Snijesh","middleName":"V","lastName":"P","suffix":""},{"id":264719976,"identity":"b53f4cc3-82fa-4857-9912-dedc27236ea3","order_by":1,"name":"Vidya P. Nimbalkar","email":"","orcid":"https://orcid.org/0000-0001-7209-2387","institution":"Division of Molecular Medicine, St. John’s Medical College, St. John’s Research Institute, Bangalore, Karnataka, India","correspondingAuthor":false,"prefix":"","firstName":"Vidya","middleName":"P.","lastName":"Nimbalkar","suffix":""},{"id":264719977,"identity":"58a72918-0226-4cd9-81eb-2e715bfdeb29","order_by":2,"name":"Sharada Patil","email":"","orcid":"","institution":"Division of Molecular Medicine, St. John’s Medical College, St. John’s Research Institute, Bangalore, Karnataka, India","correspondingAuthor":false,"prefix":"","firstName":"Sharada","middleName":"","lastName":"Patil","suffix":""},{"id":264719978,"identity":"5881d70f-00af-4ad8-9de9-e2039d0b3ae2","order_by":3,"name":"Savitha Rajarajan","email":"","orcid":"","institution":"Division of Molecular Medicine, St. John’s Medical College, St. John’s Research Institute, Bangalore, Karnataka, India","correspondingAuthor":false,"prefix":"","firstName":"Savitha","middleName":"","lastName":"Rajarajan","suffix":""},{"id":264719979,"identity":"997c4d0e-c146-483d-90b1-5108652a1734","order_by":4,"name":"Anupama C. E.","email":"","orcid":"","institution":"Division of Molecular Medicine, St. John’s Medical College, St. John’s Research Institute, Bangalore, Karnataka, India","correspondingAuthor":false,"prefix":"","firstName":"Anupama","middleName":"C.","lastName":"E.","suffix":""},{"id":264719980,"identity":"7904dbe2-b396-456f-ae31-6d41154f7963","order_by":5,"name":"Mahalakshmi S","email":"","orcid":"","institution":"Division of Molecular Medicine, St. John’s Medical College, St. John’s Research Institute, Bangalore, Karnataka, India","correspondingAuthor":false,"prefix":"","firstName":"Mahalakshmi","middleName":"","lastName":"S","suffix":""},{"id":264719981,"identity":"bdfb47a5-656f-4324-be4f-6170db6fa8ca","order_by":6,"name":"Annie Alexander","email":"","orcid":"","institution":"Division of Molecular Medicine, St. John’s Medical College, St. John’s Research Institute, Bangalore, Karnataka, India","correspondingAuthor":false,"prefix":"","firstName":"Annie","middleName":"","lastName":"Alexander","suffix":""},{"id":264719982,"identity":"7f1a0131-d055-441c-981b-c4f13fcd7584","order_by":7,"name":"Soundharya R","email":"","orcid":"","institution":"Centre for BioSystems Science and Engineering, Indian Institute of Science, Bengaluru, India","correspondingAuthor":false,"prefix":"","firstName":"Soundharya","middleName":"","lastName":"R","suffix":""},{"id":264719983,"identity":"6da96166-4a71-4970-85af-93cc9749915d","order_by":8,"name":"Rakesh Ramesh","email":"","orcid":"","institution":"Department of Surgical Oncology, St. John’s Medical College and Hospital, Bangalore, Karnataka, India","correspondingAuthor":false,"prefix":"","firstName":"Rakesh","middleName":"","lastName":"Ramesh","suffix":""},{"id":264719984,"identity":"1ba03a34-15b3-4222-90e8-18896fa1aeef","order_by":9,"name":"B. S. Srinath","email":"","orcid":"","institution":"Department of Surgery, Sri Shankara Cancer Hospital and Research Centre, Bangalore, Karnataka, India","correspondingAuthor":false,"prefix":"","firstName":"B.","middleName":"S.","lastName":"Srinath","suffix":""},{"id":264719985,"identity":"ba3f51d9-d844-4692-97b1-4d9e2bdb4e2f","order_by":10,"name":"Mohit Kumar Jolly","email":"","orcid":"https://orcid.org/0000-0002-6631-2109","institution":"Centre for BioSystems Science and Engineering, Indian Institute of Science, Bengaluru, India","correspondingAuthor":false,"prefix":"","firstName":"Mohit","middleName":"Kumar","lastName":"Jolly","suffix":""},{"id":264719986,"identity":"a540eb91-f402-4565-a9ae-7296f94ffd0a","order_by":11,"name":"Jyothi S. Prabhu","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAzUlEQVRIiWNgGAWjYBACxgYGBmYGAxsgA8QEAjYitDA2MxikkaAFpKuZgeEwCQ5jnpF8/HFBwXl75tmHG5grKuoY+KQbCFgxIy2xeYbB7cTGvsQGxjNnDjOwyRwgpCXHsJnH4HYCYw/QN41tBxjYJBKI0nLOHqLlXx3RWg4wNoK1NDAToaXnWeJsHoPkRJCWgw3HDvMQ1GLYnnzgM88fO3vDHvaHDxtq6uTkZxDSMgGqwLCBgeEAkObBrx4I5PkPQBkElY6CUTAKRsGIBQCq9j/k+GpSqgAAAABJRU5ErkJggg==","orcid":"https://orcid.org/0000-0002-2269-3704","institution":"Division of Molecular Medicine, St. John’s Medical College, St. John’s Research Institute, Bangalore, Karnataka, India","correspondingAuthor":true,"prefix":"","firstName":"Jyothi","middleName":"S.","lastName":"Prabhu","suffix":""}],"badges":[],"createdAt":"2024-01-02 09:18:21","currentVersionCode":1,"declarations":{"humanSubjects":true,"vertebrateSubjects":false,"conflictsOfInterestStatement":false,"humanSubjectEthicalGuidelines":true,"humanSubjectConsent":true,"humanSubjectClinicalTrial":false,"humanSubjectCaseReport":false,"vertebrateSubjectEthicalGuidelines":false},"doi":"10.21203/rs.3.rs-3829052/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-3829052/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":49129014,"identity":"7ef869e9-79dd-4268-a151-4c6202081d44","added_by":"auto","created_at":"2024-01-03 15:12:59","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1271627,"visible":true,"origin":"","legend":"","description":"","filename":"Differentialroleofglucocorticoidreceptorbasedonitscelltypespecificexpressionontumorcellsandinfiltratinglymphocytes.pdf","url":"https://assets-eu.researchsquare.com/files/rs-3829052/v1_covered_74586306-d5c6-46d6-b355-5048ecac8d31.pdf"}],"financialInterests":"\u003cp\u003eThe authors declare no competing interests.\u003c/p\u003e\n\u003cp\u003eSupplementary Figures and Tables are not available with this version.\u003c/p\u003e","formattedTitle":"\u003cp\u003eDifferential role of glucocorticoid receptor based on its cell type specific expression on tumor cells and infiltrating lymphocytes\u003c/p\u003e","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"St. John's Research Institute","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Glucocorticoid receptor, Gene signature, Proliferation, Tumor microenvironment, Epithelial to mesenchymal transition, Prognosis","lastPublishedDoi":"10.21203/rs.3.rs-3829052/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-3829052/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003eBackground\u003c/strong\u003e: The glucocorticoid receptor (GR) is frequently expressed in breast cancer (BC), and its prognostic implications are contingent on estrogen receptor (ER) status. To address conflicting reports and explore therapeutic potential, a GR signature (GRsig) independent of ER status was developed. We also investigated cell type-specific GR protein expression in BC tumor epithelial cells and infiltrating lymphocytes.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMethods\u003c/strong\u003e: GRsig was derived from Dexamethasone-treated cell lines through a bioinformatic pipeline. Immunohistochemistry assessed GR protein expression. Associations between GRsig and tumor phenotypes (proliferation, cytolytic activity (CYT), immune cell distribution, and epithelial-to-mesenchymal transition(EMT)) were explored in public datasets. Single-cell RNA sequencing data evaluated context-dependent GR roles, and a cell type-specific prognostic role was assessed in an independent BC cohort.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eResults\u003c/strong\u003e: High GRsig levels were associated with a favorable prognosis across BC subtypes. Tumor-specific high GRsig correlated with lower proliferation, increased CYT, and anti-tumorigenic immune cells. Single-cell data analysis revealed higher GRsig expression in immune cells, negatively correlating with EMT while a positive correlation was observed with EMT primarily in tumor and stromal cells. Univariate and multivariate analyses demonstrated the robust and independent predictive capability of GRsig for favorable prognosis. GR protein expression on immune cells in triple-negative tumors indicated a favorable prognosis.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConclusion\u003c/strong\u003e: This study underscores the cell type-specific role of GR, where its expression on tumor cells is associated with aggressive features like EMT, while in infiltrating lymphocytes, it predicts a better prognosis, particularly within TNBC tumors. The GRsig emerges as a promising independent prognostic indicator across diverse BC subtypes.\u003c/p\u003e","manuscriptTitle":"Differential role of glucocorticoid receptor based on its cell type specific expression on tumor cells and infiltrating lymphocytes","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-01-03 15:04:46","doi":"10.21203/rs.3.rs-3829052/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"b4dc7f35-cfbd-4210-9337-8b1c13faeb95","owner":[],"postedDate":"January 3rd, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":27891950,"name":"Cancer Biology"},{"id":27891951,"name":"Bioinformatics"},{"id":27891952,"name":"Translational Medicine"},{"id":27891953,"name":"Oncology"}],"tags":[],"updatedAt":"2024-01-03T15:04:46+00:00","versionOfRecord":[],"versionCreatedAt":"2024-01-03 15:04:46","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-3829052","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-3829052","identity":"rs-3829052","version":["v1"]},"buildId":"qtupq5eGEP_6zYnWcrvyt","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00